acute myeloid leukemia
An aggressive blood cancer of the bone marrow; the disease Raza has studied and treated since 1977.
As defined in 77 | Azra Raza on The Way We Should Fight Cancer
Where it comes up · 3
- Azra Raza on The First Cell3 claims
- 77 | Azra Raza on The Way We Should Fight Cancer2 claims
- 98 - Into The Dark Land1 claim
Most important claims · 6 of 6Search all claims for “acute myeloid leukemia” →
- Acute myeloid leukemia is treated in 2019 with the exact same two-chemotherapy combination, known as '7+3', that was used in 1977, with the same side effects and the same dreadful results decade after decade.77 | Azra Raza on The Way We Should Fight Cancer
- Because acute myeloid leukemia is too aggressive to cure once established, the best strategy is to stop it before it accelerates by studying its pre-leukemic precursor—myelodysplastic syndromes, a third of which progress to AML—and intervening there; this is why Raza built a longitudinal tissue repository of over 60,000 serial samples since 1984 rather than building a mouse model.77 | Azra Raza on The Way We Should Fight Cancer
- Genome sequencing has a fundamental shortcoming: in cancers like acute myeloid leukemia, many of the mutated genes identified by routine sequencing have no available therapy, so doctors gain knowledge without a way to treat those cancers, contrary to early hopes that sequencing would yield dozens of immediately targetable drug targets.98 - Into The Dark Land
- Raza was giving the same two drugs to treat acute myeloid leukemia in 1977 that she still uses in 2020, with the same dreadful results—and to this day we still don't know the precise mechanism of action of those two drugs.Azra Raza on The First Cell
- Myelodysplastic syndromes (MDS) are a group of pre-leukemic conditions in which blood counts fall and anemia develops; MDS is a disease in itself that can kill, but about a third of these patients go on to develop acute myeloid leukemia and die.Azra Raza on The First Cell
- Acute myeloid leukemia is a liquid cancer that is easier to study than a solid tumor like lung or ovarian cancer, which is why Raza focused on it when she began her career in 1977.Azra Raza on The First Cell